Recent Advances in Two-Dimensional Liquid Chromatography Separations
This Tuesday morning symposium, organized by Dwight Stoll of Gustavus Adolphus College, brings together experts in liquid chromatography (LC) to discuss recent advances in two dimensional (2D)-LC separations of small and large molecules. Different perspectives from instrument manufacturers, users in the pharmaceutical industry, and academic laboratories will be presented as well as a discussion on some samples related to pharmaceutical and biopharmaceutical applications.
Session 760
Room 311AB
8:30–11:45 a.m.
This Tuesday morning symposium, organized by Dwight Stoll of Gustavus Adolphus College, brings together experts in liquid chromatography (LC) to discuss recent advances in two dimensional (2D)-LC separations of small and large molecules. Different perspectives from instrument manufacturers, users in the pharmaceutical industry, and academic laboratories will be presented as well as a discussion on some samples related to pharmaceutical and biopharmaceutical applications.
The first talk will be given by Stoll and is titled “Development of Active Solvent Modulation as a Versatile Approach to Improve the Compatibility of Different Separation Modes Used in 2D-LC.” In this presentation, Stoll will describe recent insights on the utility active solvent modulation (ASM) obtained from both simulations and experiments. In addition, he will present results of representative 2D-LC separations of peptides and proteins that illustrate the utility of the ASM approach.
The next talk will be given by Brooke M. Koshel of Waters Corporation titled “Two-Dimensional Liquid Chromatography Coupled to Mass Spectrometry for Impurity Analysis of Oligonucleotides.” In this presentation, modified oligonucleotides will be analyzed using 2D-LC coupled to mass spectrometry (MS) to address the challenges faced when selecting a mobile phase to optimize both chromatography and mass spectrometry. By incorporating a second-dimension separation and at-column-dilution, sensitivity is improved to detect impurities that are not readily detectable through one-dimensional chromatography alone.
The third talk is titled “Enantioselective Analysis Using Multidimensional Liquid Chromatography,” and will be presented by Jeannie Horak of the University of Tuebingen. In this presentation, the different modalities of enantioselective multidimensional LC, such as offline LCxLC, online multiple heart cutting, high resolution sampling (selective comprehensive), and fully comprehensive LCxLC, will be discussed. The advantages, challenges, problems and how they can be overcome, and disadvantages of each modality will be outlined by Horak using real applications from pharmaceutical analysis to biotechnology.
After a brief recess, Stephan Buckenmaier of Agilent Technologies will present a talk titled “Improvements in 2D-LC Applications Enabled by New Instrument Technology.” This presentation will focus on a technique referred to as multiple heart-cutting 2D-LC, which breaks the link between the 1D and 2D separation timescales allowing for operation of both dimensions nearly independently.
The final talk in this session is titled “Characterization of Biocompatible Polymers for Drug Conjugation by 2DLC-QTOF,” and will be presented by Kelly Zhang of Genentech. Zhang will discuss the use of 2DLC-QTOF with charge reduction mass spectrometry to deconvolute the polymer distributions to lower charge states to identify and characterize the heterogenous polymer profile and its maleimide related species.
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
